Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;124(3):449-51.
doi: 10.1007/s00401-012-1011-7. Epub 2012 Jul 8.

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas

Benjamin Ellezam, Brett J Theeler, Tobias Walbert, Aaron G Mammoser, Craig Horbinski, Bette K Kleinschmidt-DeMasters, Arie Perry, Vinay Puduvalli, Gregory N Fuller, Janet M Bruner, Kenneth D Aldape

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas

Benjamin Ellezam et al. Acta Neuropathol. 2012 Sep.
No abstract available

PubMed Disclaimer

References

    1. Camelo-Piragua S, Jansen M, Ganguly A, Kim JC, Cosper AK, Dias-Santagata D, Nutt CL, Iafrate AJ, Louis DN. A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53. J Neuropathol Exp Neurol. 2011;70:110–115. - PMC - PubMed
    1. Capper D, Reuss D, Schittenhelm J, Hartmann C, Bremer J, Sahm F, Harter PN, Jeibmann A, von Deimling A. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol. 2011;121:241–252. - PubMed
    1. Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J. Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Am J Surg Pathol. 2010;34:1199–1204. - PubMed
    1. Capper D, Weissert S, Balss J, et al. Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol. 2010;20:245–254. - PMC - PubMed
    1. Capper D, Zentgraf H, Balss J, Hartmann C, Deimling A. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol. 2009;118:599–601. - PubMed

Publication types

Substances

LinkOut - more resources